Literature DB >> 6611597

Small intestine transplantation in the rat--immunology and function.

R L Kirkman, P A Lear, J L Madara, N L Tilney.   

Abstract

Heterotopic, vascularized small intestine transplants were performed in inbred strains of rats to investigate the structural, functional, and immunologic consequences of intestinal transplantation with and without immunosuppression with cyclosporine (CyA). Lewis X Brown Norway F1 intestine was rejected by untreated Lewis recipients in 7 to 10 days. Structurally, rejected intestine was characterized by shortened crypts and villi lined by damaged attenuated epithelial cells. Functionally, rejection was associated with impaired epithelial active ion transport as indicated by decreased potential difference and with diminished epithelial barrier function as reflected by decreased transepithelial resistance. Administration of CyA for 7 days prevented clinical rejection and partially prevented the structural and functional defects. Lewis intestine transplanted into Lewis X Brown Norway F1 recipients caused fatal graft versus host disease (GVHD) in 9 to 17 days. Treatment with CyA for 7 days failed to prevent GVHD routinely, but prolonged administration delayed fatal GVHD until CyA was discontinued. Intestine from Lewis "B" rats made deficient of T cells by thymectomy, irradiation, and reconstitution with syngeneic T cell-depleted bone marrow failed to cause GVHD in Lewis recipients. Reconstitution of the "B" rats with T cells before transplantation restored the GVHD response. These results may be relevant in the consideration of clinical small intestinal transplantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611597

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Reduction of graft-versus-host reactivity after small bowel transplantation: ex vivo treatment of intestinal allografts with an anti-T cell immunotoxin.

Authors:  C L Clark; G J Smith; P W Crane; B A Price; P A Lear; J W Fabre; R F Wood
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 2.  Recent progress in intestinal transplantation.

Authors:  C I Clark
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 3.  Absorptive function following small intestinal transplantation.

Authors:  J Kim; J Fryer; R M Craig
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

4.  Transplantation of multiple abdominal viscera.

Authors:  T E Starzl; M I Rowe; S Todo; R Jaffe; A Tzakis; A L Hoffman; C Esquivel; K A Porter; R Venkataramanan; L Makowka
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

Review 5.  Small bowel transplantation.

Authors:  T J Pritchard; R L Kirkman
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

6.  Structural and functional evolution of jejunal allograft rejection in rats and the ameliorating effects of cyclosporine therapy.

Authors:  J L Madara; R L Kirkman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Graft-versus-host disease after small bowel transplantation is associated with host colonic injury.

Authors:  W A Koltun; M M Bloomer; P C Colony; F M Ruggiero; G L Kauffman
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

8.  Value of in vivo electrophysiological measurements to evaluate canine small bowel autotransplants.

Authors:  M A Meijssen; E Heineman; R W de Bruin; H J Veeze; J Bijman; H R de Jonge; F J ten Kate; R L Marquet; J C Molenaar
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

9.  Effect of cyclosporin A on rat mucosal mast cells and the associated protease RMCPII.

Authors:  A G Cummins; G H Munro; A Ferguson
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

10.  The effect of donor-specific transfusion and cyclosporin A on small bowel transplantation in the rat.

Authors:  S F Santiago; M Fukuzawa; T Azuma; R Nezu; K Imura; Y Takagi; A Okada
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.